drugset / Trial / NCT01534247

A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately

NCT01534247

Phase 1 Completed 28 enrolled Pfizer Forest Laboratories · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of the study is to assess whether there is any pharmacokinetic interactions between CAZ-AVI and metronidazole.

Timeline

Start
2012-02
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftazidime Small molecule 2000 mg Other
Comparator Metronidazole Small molecule 500 mg Other
Subject avibactam Small molecule 500 mg Other

Indications

No indication recorded.